Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
A control series of 105 patients in hospital with non-malignant diseases was used in a limited clinical assessment of the MOD-MEM test. Twenty-seven positive results could be explained on the basis of destruction of nervous parenchyma, tissue necrosis, tuberculosis, malignant disease, etc. The remaining 13 unexplained positives showed a sex and age distribution in agreement with that predicted from cancer registration statistics if the MOD-MEM test detects cancer about 16 years before the clinical appearance of the disease.
D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008214:Lymphocytes; D008264:Macrophages / Q000276:immunology*; D008297:Male; D004676:Myelin Basic Protein / Q000276:immunology; D009369:Neoplasms / Q000175:diagnosis*; D013997:Time Factors
D004676:Myelin Basic Protein